Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare (NHC) Non Operating Income (2017 - 2025)

Historic Non Operating Income for National Healthcare (NHC) over the last 9 years, with Q3 2025 value amounting to $4.7 million.

  • National Healthcare's Non Operating Income rose 1032.2% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year decrease of 367.36%. This contributed to the annual value of $19.7 million for FY2024, which is 1818.73% up from last year.
  • Per National Healthcare's latest filing, its Non Operating Income stood at $4.7 million for Q3 2025, which was up 1032.2% from $5.1 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Non Operating Income registered a high of $6.3 million during Q1 2021, and its lowest value of $2.5 million during Q2 2022.
  • In the last 5 years, National Healthcare's Non Operating Income had a median value of $4.2 million in 2024 and averaged $4.2 million.
  • As far as peak fluctuations go, National Healthcare's Non Operating Income tumbled by 6697.14% in 2021, and later soared by 6892.19% in 2023.
  • National Healthcare's Non Operating Income (Quarter) stood at $2.5 million in 2021, then rose by 6.37% to $2.7 million in 2022, then surged by 68.92% to $4.5 million in 2023, then increased by 6.18% to $4.8 million in 2024, then fell by 3.42% to $4.7 million in 2025.
  • Its Non Operating Income was $4.7 million in Q3 2025, compared to $5.1 million in Q2 2025 and $4.1 million in Q1 2025.